Fujian Haixi Pharmaceuticals Co., Ltd. Class H (2637) Stock Forecast & Price Target
2637 Analyst Ratings
Strong Buy
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to Fujian Haixi Pharmaceuticals Co., Ltd. Class H in the past 3 months
2637 Stock 12 Month Forecast
Average Price Target
HKD 296.79▲(113.06% Upside)Based on 4 Wall Street analysts offering 12 month price targets for Fujian Haixi Pharmaceuticals Co., Ltd. Class H in the last 3 months. The average price target is HKD 296.79 with a high forecast of HKD 339.55 and a low forecast of HKD 266.80. The average price target represents a 113.06% change from the last price of HKD 139.30.
Past 12 Months12 Month ForecastDec2025Sep2026
HighHKD 339.55
AverageHKD 296.79
LowHKD 266.80
Highest Price TargetHighestHKD 339.55Average Price TargetHKD 296.79Lowest Price TargetLowestHKD 266.80
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Huafu Securities | HKD 300.80 | buy | 115.94%Upside | Reiterated | 10/11/26 | ||
| Jill Wu | CMB International Securities | HKD 280 | buy | 101.01%Upside | Reiterated | 09/18/26 | ||
| Unknown AnalystNot Ranked | SDIC Securities | HKD 266.80 | buy | 91.53%Upside | Reiterated | 09/08/26 | ||
| Unknown AnalystNot Ranked | Guohai Securities | HKD 339.55 | buy | 143.75%Upside | Reiterated | 08/31/26 | ||
| Unknown AnalystNot Ranked | Guotai Haitong | HKD 298.99 | buy | 114.64%Upside | Reiterated | 07/02/26 | ||
| Unknown AnalystNot Ranked | Northeast Securities | HKD 346.75 | buy | 148.92%Upside | Reiterated | 05/08/26 | ||
| Unknown AnalystNot Ranked | Shenwan Hongyuan | HKD 298.28 | buy | 114.13%Upside | Reiterated | 04/24/26 | ||
| Unknown AnalystNot Ranked | SWS Res | HKD 298.28 | buy | 114.13%Upside | Reiterated | 04/23/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Unknown AnalystNot Ranked | 10/11/26 | HKD 300.80 | buy | 115.94%Upside | Reiterated | Huafu Securities | ||
| Jill Wu | 09/18/26 | HKD 280 | buy | 101.01%Upside | Reiterated | CMB International Securities | ||
| Unknown AnalystNot Ranked | 09/08/26 | HKD 266.80 | buy | 91.53%Upside | Reiterated | SDIC Securities | ||
| Unknown AnalystNot Ranked | 08/31/26 | HKD 339.55 | buy | 143.75%Upside | Reiterated | Guohai Securities | ||
| Unknown AnalystNot Ranked | 07/02/26 | HKD 298.99 | buy | 114.64%Upside | Reiterated | Guotai Haitong | ||
| Unknown AnalystNot Ranked | 05/08/26 | HKD 346.75 | buy | 148.92%Upside | Reiterated | Northeast Securities | ||
| Unknown AnalystNot Ranked | 04/24/26 | HKD 298.28 | buy | 114.13%Upside | Reiterated | Shenwan Hongyuan | ||
| Unknown AnalystNot Ranked | 04/23/26 | HKD 298.28 | buy | 114.13%Upside | Reiterated | SWS Res |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering Fujian Haixi Pharmaceuticals Co., Ltd. Class H
3 Months
Success Rate1/2 ratings generated profit
50%
Average Return
-10.90%
Copying Jill Wu's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -10.90% per trade.
1 Year
Success Rate0/2 ratings generated profit
0%
Average Return
-24.05%
Copying Jill Wu's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -24.05% per trade.
2 Years
Success Rate0/2 ratings generated profit
0%
Average Return
-24.05%
Copying Jill Wu's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -24.05% per trade.
2637 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 2 | 2 |
| Buy | 5 | 3 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 6 | 5 | 4 | 4 | 4 |
In the current month, 2637 has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2637 average Analyst price target in the past 3 months is 296.79.
2637 Financial Forecast
2637 Stock Forecast FAQ
What is HK:2637’s average 12-month price target, according to analysts?
Based on analyst ratings, Fujian Haixi Pharmaceuticals Co., Ltd. Class H’s 12-month average price target is HK$296.79.
What is HK:2637’s upside potential, based on the analysts’ average price target?
Fujian Haixi Pharmaceuticals Co., Ltd. Class H has 113.06% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fujian Haixi Pharmaceuticals Co., Ltd. Class H a Buy, Sell or Hold?
Fujian Haixi Pharmaceuticals Co., Ltd. Class H has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Fujian Haixi Pharmaceuticals Co., Ltd. Class H’s share price target?
The average share price target for Fujian Haixi Pharmaceuticals Co., Ltd. Class H is HK$296.79. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$339.55, and the lowest forecast is HK$266.80. The average share price target represents a 113.06% increase from the current price of HK$139.3.
What do analysts say about Fujian Haixi Pharmaceuticals Co., Ltd. Class H?
Fujian Haixi Pharmaceuticals Co., Ltd. Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Fujian Haixi Pharmaceuticals Co., Ltd. Class H?
To buy shares of HK:2637, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
